UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 2549

 

FORM N-PX

 

Investment Company Act File Number: 811-22299

 

RENN Fund, Inc.

(Exact name of Registrant as specified in charter)

c/o Horizon Asset Management LLC

470 Park Avenue South

New York, New York

10016

(Address of Principal Executive Offices)

(Zip Code)

 

Russell G. Cleveland

11520 North Central Expressway, Suite 162

Dallas, Texas 75243

(Name and Address of Agent for Service)

 

Registrant’s telephone number: 646-495-7330

Date of Fiscal Year-End: 12/31/2016

Date of reporting period: 07/01/2016 – 06/30/2017

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CRR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.

 

Item 1: Proxy Voting Record.

 

Disclosed is the following information for each matter relating to a portfolio security considered at any shareholder meeting held during the period covered by the report and with respect to which the registrant was entitled to vote:

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: RENN Fund, Inc.
   
By: /s/  Russell Cleveland
Title: President, CEO, and Director
Date: August 31, 2017

 

 

 

 

 

 

 

Bovie Medical Corporation    
Ticker: BVX Security ID: 10211F100
Meeting Date: July 28, 2016 Meeting Type: Annual
Record Date: June 10, 2106    

 

Item: Matter to be Voted On: Proposed by: Shares Voted: How Voted: For or Against Management:
1.0 Elect eight directors to the Board of Directors of the Company to serve until the 2017 Annual Meeting of Stockholders        
1.1 Andrew Makrides Management Yes For For
1.2 Robert L. Gershon Management Yes For For
1.3 J. Robert Saron Management Yes For For
1.4 Charles T. Orsatti Management Yes For For
1.5 Michael Geraghty Management Yes For For
1.6 Lawrence J. Waldman Management Yes For For
1.7 John C. Andres Management Yes For For
1.8 Scott Davidson Management Yes For For
2.0 The ratification of Frazier & Deeter, LLC as the Company’s independent public accountants for the year ending December 31, 2016. Management Yes For For
3.0 The approval of a non-binding advisory resolution supporting the compensation of our named executive officers. Management Yes For For

 

 

 

 

 

 


FitLife Brands
   
Ticker: FTLF Cusip #: 33817P108
Meeting Date: June 22, 2017 Meeting Type: Annual
Record Date: June 5, 2017    

 

Item: Matter to be Voted On: Proposed by: Shares Voted: How Voted: For or Against Management:
1.0 Esection of Directors: Management Yes For For
1.1 John S. Wilson Management Yes For For
1.2 Michael Abrams Management Yes For For
1.3 Lewis Jaffe Management Yes For For
1.4 Grant Dawson Management Yes For For
1.5 Seth Yakatan Management Yes For For
1.6 Todd Ordal Management Yes For For
17 Dayton Judd Management Yes For For
           
2.0 An Advisory Vote regarding the approval of compensation paid to our named executive officers Management Yes For For
3.0 Ratifying the appointment of Weinberg & Company P.A. as FitLife Brands, Inc.’s independent auditor for the fiscal year ending December 31, 2017. Management Yes For For